浙江奥翔药业股份有限公司 (Zhejiang Aoxiang Pharmaceutical Co., Ltd.) focuses on the research and development of innovative pharmaceutical products, particularly in the fields of oncology and autoimmune diseases. The company employs advanced drug discovery technologies, including high-throughput screening and structure-based drug design, to identify and optimize potential therapeutic candidates. Their commitment to innovation is evident in their robust pipeline, which features a range of novel compounds aimed at addressing unmet medical needs in various therapeutic areas.

In addition to their drug development efforts, 浙江奥翔药业 emphasizes the importance of scientific research and collaboration. The company invests in cutting-edge technologies such as biopharmaceutical manufacturing processes and formulation development to ensure the efficacy and safety of their products. By leveraging state-of-the-art analytical techniques and quality control measures, they aim to deliver high-quality pharmaceuticals that meet international standards, thereby enhancing patient outcomes and contributing to global health advancements.

China

公司的主营业务为特色原料药、医药中间体的研发、生产和销售，以及为客户提供定制加工和研发业务。产品具有手性结构多、研发难度大、技术壁垒高、生产工艺独特等特点。公司是高新技术企业，被认定为“省级高新技术企业研究开发中心”、“省级企业研究院”，公司拥有院士工作站、博士后工作站、博士后创新实践基地等优秀的研发平台，与诸多高校、研究所保持良好的研发合作关系。

浙江奥翔药业股份有限公司

Company Details